Frequency and Prognostic Impact of Local Ablation Therapy for Oligoprogression in Non‐Small Cell Lung Cancer
Although this study found no significant prognostic benefit of LAT in patients with OP, future research integrating clinical and molecular data may identify patients most likely to benefit from LAT.
Authors
- Megumi Furuta (ORCID: https://orcid.org/0000-0002-1291-3988)
- Risa Kamada
- Hidenori Kitai (ORCID: https://orcid.org/0000-0001-6372-846X)
- Shotaro Ito
- Satoshi Konno (ORCID: https://orcid.org/0000-0001-6439-2443)
- Kanako C. Hatanaka (ORCID: https://orcid.org/0009-0008-9596-9661)
- Jun Sakakibara‐Konishi (ORCID: https://orcid.org/0000-0003-4333-8100)
- Daisuke Morinaga (ORCID: https://orcid.org/0000-0003-2810-4293)
- Yoshiki Shinomiya
- Hiroshi Taguchi (ORCID: https://orcid.org/0000-0003-2348-4071)
- Yasuyuki Ikezawa (ORCID: https://orcid.org/0000-0002-8054-6091)
- Tatsuya Kato (ORCID: https://orcid.org/0000-0003-4063-0042)
- Yutaka Hatanaka (ORCID: https://orcid.org/0000-0003-3128-1477)
- Yuta Takashima (ORCID: https://orcid.org/0000-0002-0136-520X)
- Kosuke Tsuji (ORCID: https://orcid.org/0000-0003-4851-3721)
- Tetsuaki Shoji
- Masahiro Kashima
Institutions
- Hokkaido University (JP)
- Hokkaido University Hospital (JP)
Publication Details
- Journal
- Thoracic Cancer
- Published
- 2025-07-01
- DOI
- https://doi.org/10.1111/1759-7714.70119
- Citations
- 2
- Primary Topic
- Lung Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 3.04